General MedicationsORALStandard

RIVASTIGMINE TARTRATE

Standard Dose

EQ 4.5MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview RIVASTIGMINE TARTRATE is listed in Drugs@FDA under application 207797 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient RIVASTIGMINE TARTRATE Form and strength CAPSULE;ORAL - EQ 4.5MG BASE Sponsor CHARTWELL RX Submission history Latest submission status date: 2017-09-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview RIVASTIGMINE TARTRATE is listed in Drugs@FDA under application 207797 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RIVASTIGMINE TARTRATE Form and strength CAPSULE;ORAL - EQ 4.5MG BASE Sponsor CHARTWELL RX Submission history Latest submission status date: 2017-09-28 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.